Shopping Cart (0)
My Account

Your Shopping Cart
Metabomeeting 2014Drug Discovery India 2014Enabling Genomic Technologies and Screening Asia 2014Drug Metabolism & Discovery ADMETIndian Lab Automation20% Discount OfferePoster Award PrizeBlogs

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012

Publisher: Select Biosciences
Published: January 2012
Pages: 122

Price:



This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) and cancer stem cells (CSCs) fields.  In this report, we focus upon the biology of CTCs and CSCs as well as explore the inter-relationship between these cell types based upon molecular events.  Also presented are research trends which are for the isolation and study of CTCs, a potentially important tool for cancer diagnostics with special relevance to cancer metastatic mechanisms

This report analyzes the CTCs marketplace from a technical as well as market perspective describing the biology of CTCs, methodologies currently in use for the purification and study of CTCs, as well as the market landscape for CTCs.

This report also describes the current state of the CSC marketplace based on data from research, market landscape, and clinical trial angles

This is the first report in its class providing a technical as well as a market analysis of CTCs and CSCs.  Data in this report includes a primary market survey performed describing the research trends currently in the CTCs and CSCs spaces including:

  • Surface markers currently used to study CTCs and CSCs
  • Intracellular signaling pathways analyzed in CSCs
  • Quantitative Breakout of Cancer Classes where CTCs are being studied
  • Market Shares of Vendors Offering Products into the CTC and CSC Spaces
  • Breakout of the Marketplace vis-à-vis Technologies/Approaches for Study of CTCs
  • Quantitative Market Metrics for CTCs Space: Quantitative Market Forecast, Growth Rate

This data-driven characterization of the CTCs and CSCs landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans

Extensive Technical and Market Analyses Presented in this Report

  • Biology of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
    • Characteristics of CTCs and DTCs
    • EMT Signaling Pathways and Molecular Effectors
    • Markers for CSCs
  • Circulating Tumor Cells (CTCs) Research Approaches
    • Methodologies for Study/Analysis of CTCs
    • CTC Detection Approaches
    • New Molecular Targets for CTC Detection Broadening the “CTC Classes” in Various Types of Cancer
    • Advantages and Disadvantages of Various CTC Analysis Approaches
  • Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Landscape
    • CTCs and CSCs: Primary Market Research Data, Research Trends
    • Product Market Shares
    • Quantitative Market Metrics: Market Sizing, Growth Rate
    • Clinical Trial Quantitative Metrics and Analysis

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$ 255 - EARLY BIRD DEADLINE 10 OCTOBER 2014!


Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access


Papers Presented in Enabling Genomic Technologies & Screening Asia can be Published in CSBJ
Papers Presented in Enabling Genomic Technologies & Screening Asia can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Enabling Genomic Technologies & Screening Asia conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access Journals.


Submission Deadline Extended to the 15 August 2014
Submission Deadline Extended to the 15 August 2014
Submit your abstract for consideration to present at Lab-on-a-Chip Asia - Microfluidics and Point-of-Care Diagnostics.


Papers presented in Drug Discovery India 2014 conference will be published in CRDD.
Papers presented in Drug Discovery India 2014 conference will be published in CRDD.
The Proceedings of Drug Discovery India 2014 conference will be published in a Special Issue of Current Research in Drug Discovery (CRDD) an online, free access, peer reviewed journal. To make the conference proceedings a timely publication, the authors are requested to submit the manuscripts prior to the start of the conference.


Agenda now on-line - Enabling Genomic Technologies and Screening Asia 2014
Agenda now on-line - Enabling Genomic Technologies and Screening Asia 2014
The agenda for Enabling Genomic Technologies and Screening Asia 2014 is now on-line. Don't miss out on our Early Bird Pricing - Register Today!

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com